A soluble insulin-like growth factor I receptor that induces apoptosis of tumor Cells in vivo and inhibits tumorigenesis

Cancer Research

Volumn 56, Issue 17, 1996, Pages 4013-4020

  D'Ambrosio, Consuelo ^a   Ferber, Andres ^a   Resnicoff, Mariana ^a   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; SOMATOMEDIN C RECEPTOR;

ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CARCINOGENESIS; CELL GROWTH; CENTRAL NERVOUS SYSTEM TUMOR; FRAMESHIFT MUTATION; GLIOBLASTOMA; GROWTH INHIBITION; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL CULTURE;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CULTURE MEDIA; GLIOBLASTOMA; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; SOLUBILITY; TYROSINE;

EID: 0029791877     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosme kinase activity. Cell, 61: 203-212, 1990.
2. Ullrich, A , Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C , Henzel, W., Le Bon, T , Kahuna, S., Chen, E., Jakobs, S., Francke, U., Ramachandran, J , and Fujita-Yamaguchi, Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J , 5: 2503-2512, 1986.
3. Baserga, R The insulin-like growth factor I receptor, a key to tumor growth? Cancer Res., 55: 249-252, 1995.
4. Scher, C D , Shephard, R. C , Antoniades, H. N., and Stiles, C. D Platelet-derived growth factor and the regulation of the mammalian fibroblasts cell cycles. Biochim. Biophys. Acta, 560: 217-241, 1979.
5. Stiles, C D., Capone, G. T., Scher, C D , Antoniades, N H., Van Wyk, J. J., and Pledger, W. J. Dual control of cell growth by somatomedins and platelet-derived growth factor Proc Natl. Acad. Sci USA, 76: 1279-1283, 1979.
6. 1 progression in competent BALB/c3T3 cells. Exp Cell Res., 141: 107-115, 1982.
7. Liu, J P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell, 75: 59-72, 1993.
8. Baker, J , Liu, J P., Robertson, E. J., and Efstratiadis, A. Role of insulin-like growth factors m embryonic and postnatal growth. Cell, 75: 73-82, 1993.
9. Sell, C., Dumenil, G., Deveaud, C., Miura, M , Coppola, D , DeAngelis, T , Rubin, R , Efstratiadis, A., and Baserga, R Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts Mol. Cell Biol , 14: 3604-3612, 1994.
10. Sell, C., Rubini, M., Rubin, R., Liu, J P., Efstratiadis, A., and Baserga, R Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc. Natl Acad. Sci USA, 90: 11217-11221, 1993
11. Morrione, A., DeAngelis, T., and Baserga, R. Failure of the bovine papilloma virus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes. J. Virol., 69: 5300-5303, 1995
12. Coppola, D., Ferber, A., Miura, M., Sell, C , D'Ambrosio, C., Rubin, R , and Baserga, R A functional IGF-I receptor as required for the mitogenic and transforming activities of the epidermal growth factor receptor Mol. Cell. Biol., 14: 4588-4595, 1994.
13. DeAngelis, T , Ferber, A., and Baserga, R. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J Cell. Physiol., 164: 214-221, 1995
14. Miura, M., Surmacz, E , Burgaud, J. L , and Baserga, R Different effects of mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor J Biol. Chem., 270: 22639-22644, 1995.
15. Kaleko, M., Rutter, W. G , and Miller, A. D. Overexpression of the human insulin-like growth factor 1 receptor promotes ligand-dependent neoplastic transformation Mol Cell. Biol , 10: 464-473, 1990.
16. McCubrey, J. A., Stillman, L. S., Mayhew, M W., Algate, P. A., Dellow, R. A., and Kaleko, M. Growth promoting effects of insulin-like growth factor 1 (IGF-1) on hematopoietic cells: Overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor dependent cells by ligand dependent mechanism. Blood, 78: 921-929, 1991.
17. Pietrzkowski, Z., Lammers, R., Carpenter, G., Soderquist. A M., Limardo, M., Phillips, P. D., Ullrich, A., and Baserga, R. Constitutive expression of IGF-1 and IGF-1 receptor abrogates all requirements for exogenous growth factors Cell Growth & Differ., 3: 199-205, 1992.
18. Pietrzkowski, Z., Sell, C., Lammers, C R., Ullrich, A., and Baserga, R. The role of insulin like growth factor 1 (IGF-I) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell. Biol , 12: 3883-3889, 1992.
19. Liu, D., Zong, C , and Wang, L. H. Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions. J. Virol., 67: 6835-6840, 1993
20. Surmacz, E , Sell, C., Swantek, J., Kato, H., Roberts, C. T., Jr., LeRoith, D., and Baserga, R. Dissociation of mitogenesis and transforming activity by COOH-terminal truncation of the insulin-like growth factor I receptor. Exp. Cell Res , 218: 370-380, 1995.
21. Christopheri, G., Naik, P , and Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis Nature (Lond.), 369: 414-418, 1994.
22. Rogler, C. E., Yang, D., Rossetti, L., Donohoe, J , Alt, E., Chang, C. J., Rosenfeld, R., Neely, K., and Hintz, R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor H transgenic mice. J. Biol. Chem., 269: 13779-13784, 1994.
23. Trojan, J., Johnson, T. R., Rudin, S. D , Ilan, J , Tykocinski, M. L , and Ilan, I. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing anusense insulin-like growth factor I RNA. Science (Washington DC), 259: 94-97, 1993.
24. Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R., and Rubin, R Rat glioblastoma cells expressing an amisense RNA to the insulin-like growth factor I (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors Cancer Res., 54: 2218-2222, 1994.
25. Resnicoff, M., Coppola, D., Sell, C , Rubin, R., Ferrone, S., and Baserga, R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor Cancer Res , 54: 4848-4850, 1994.
26. Resnicoff, M., Abraham, D , Yutanawiboonchai, W., Rotman, H. L , Kajstura, J., Rubin, R., Zoltick, P , and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
27. Resnicoff, M , Burgaud, J. L , Rotman, H L., Abraham, D , and Baserga, R. Correlation between apoptosis, tumorisenesis, and levels of insulin-like growth factor I receptors Cancer Res., 55: 3739-3741, 1995
28. Shapiro, D. N., Jones, B. G., Shapiro, L. H , Dias, P., and Houghton, P J. Antisense-mediated reduction in insulin-like growth factor I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest., 94: 1235-1242, 1994
29. Arteaga, C L , and Osborne, C. K Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor Cancer Res., 49: 6237-6241, 1989.
30. Kalebic, T , Tsokos, M , and Helman, L J In vivo treatment with antibody against the IGF-I receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34/cdc2. Cancer Res., 54: 5531-5534, 1994.
31. Prager, D., Li, H. L., Asa, S , and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl. Acad Sci. USA, 91: 2181-2185, 1994.
32. Li, S., Ferber, A , Miura, M., and Baserga, R. Mitogenicity and transforming activity of the insulin-like growth factor I receptor with mutations in the tyrosine kinase domain. J Biol Chem., 269: 32558-32564, 1994.
33. Burgaud, J L., Resnicoff, M., and Baserga, R Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem Biophys. Res. Commun., 214: 475-481, 1995.
34. Long, L , Rubin, R., Baserga, R , and Brodt, P Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor I receptor. Cancer Res, 55: 1006-1009, 1995.
35. Rodriguez-Tarduchy, G., Collins, M K L , Garcia, I., and Lopez-Rivas, A. Insulin-like growth factor I inhibits apoptosis in IL-3- dependent hemopoietic cells J. Immunol., 149: 535-540, 1992
36. Gluckman, P., Klempt, N., Guan, J , Mallard, C , Sirimanne, E , Dragunow, M , Klempt, M , Singh, K , Williams, C , and Nilcolics, K A role for IGF-I in the rescue of CNS neurons following hypoxic-ischemic injury Biochem. Biophys Res Commun., 182: 593-599, 1992.
37. D'Mello, S. R., Galli, C , Ciotti, T., and Calissano, P Induction of apoptosis in cerebellar granule neurons by low potassium inhibition of death by insulin-like growth factor I and cAMP Proc. Natl. Acad Sci USA. 90: 10989-10993, 1993
38. Harrington, E A., Bennett, M R., Fanidi, A., and Evan, G. I. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 14: 3286-3295, 1994.
39. Sell, C., Baserga, R., and Rubin, R Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
40. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction Anal. Biochem., 162: 156-159, 1987
41. Vara, J. A , Portela, A., and Jimenez, A. Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res. 14: 4617-4624, 1986.
42. Miura, M., Li, S., and Baserga, R. Effect of a mutation of tyrosine 950 of the insulin-like growth factor 1 receptor on the growth and transformation of cells Cancer Res., 55: 663-667, 1995
43. Cook, S. J , Rubinfeld, B., Albert, I., and McCormick, F RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J., 12: 3475-3485, 1993.
44. Reiss, K., Porcu, P., Sell, C , Pietrzkowski, Z., and Baserga, R. The insulin-like growth factor I receptor is required for the proliferation of hemopoietic cells Oncogene. 7: 2243-2248, 1992.
45. White, M. F , and Kahn, C. R. The insulin signaling system. J. Biol. Chem , 269: 1-4, 1994
46. Gustafson, T. A , He, W., Craparo, A., Schaub, C. D., and O'Neill, T. J. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol., 15: 2500-2508, 1995.
47. Tartare-Deckert, S , Sawka-Verhelle, D., Murdaca, J., and Van Obberghen, E Evidence for a differential interaction of She and the insulin receptor substrate 1 (IRS-1) with the insulin-like growth factor I (IGF-I) receptor in the yeast two-hybrid system. J. Biol. Chem , 270: 23456-23460, 1995
48. Cahill, A. L., and Pearlman, R. L. Activation of a microtubule-associated protein-2 kinase by insulin-like growth factor I in bovine chromaffin cells. J. Neurochem., 57: 1832-1839, 1991.
49. Webster, J., Prager, D., and Melmed, S. Insulin-like growth factor I activation of extracellular signal-related kinase-1 and -2 in growth hormone-secreting cells. Mol. Endocrinol , 8: 539-544, 1994.
50. Kato, H., Faria, T. N., Stannard, B., Roberts, C. T., Jr , and LeRoith, D Role of the tyrosine kinase domain in signal transduciton by the insulin-like growth factor 1 IGF-1 receptor J. Biol. Chem., 268: 2655-2661, 1993
51. Ballotti, R., Lammers, R., Scimeca, J. C., Dull, T., Schlessinger, J , Ullrich, A , and Van Obberghen, E. Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae. EMBO J., 8: 3303-3309, 1989.
52. Lammers, R., Van Obberghen, E., Ballotti, R., Schlessinger, J., and Ullrich, A. Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation. J Biol. Chem , 265: 16886-16890, 1990.
53. Taouis, M., Levy-Toledano, R., Roach, P., Taylor, S. L., and Gorden, P Rescue and activation of a binding-deficient insulin receptor J. Biol. Chem., 269; 27762-27766, 1994
54. Takata, Y , and Kobayashi, M Insulin-like growth factor I signaling through heterodimers of insulin and insulin-like growth factor I receptors. Diabete & Metab , 20: 31-36, 1994.
55. Chantry, A. The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors J. Biol. Chem , 270: 3068-3073, 1995
56. Burgaud, J. L., and Baserga, R. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor. Exp. Cell Res , in press, 1996
57. Waters, S B., Yamauchi, K., and Pessin, J. E Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signaling. J. Biol. Chem. 268: 22231-22234, 1993.
58. Rose, D. W., Satiel, A. R , Majumdar, M. Decker, S. J., and Olefsky, J. M Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction Proc. Natl. Acad. Sci. USA, 91: 797-801, 1994.
59. Pages, G., Lenormand, P., L'Allemain, G., Chambard, J. C , Meloche, S , and Pouyssegur, J. Mitogen-activated protein kinases p42/mapk and p44/mpk are required for fibroblast proliferation. Proc Natl Acad. Sci. USA, 90: 8319-8323, 1993.
60. Cowley, S , Peterson, H., Kemp, P , and Marshall, C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 77: 841-852, 1994.
61. D'Ambrosio, C., Keller, S. R , Morrione, A , Lienhard, G. E., Baserga, R , and Surmacz, E Transforming potential of the insulin receptor substrate 1, Cell Growth & Differ., 6 557-562, 1995.
62. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80: 179-185, 1995
63. Blenis, J. Signal transduction via the MAP kinases: proceed at your own RSK Proc. Natl. Acad Sci. USA, 90: 5889-5892, 1993.
64. McCormick, F. How receptors turn Ras on. Nature (Lond.), 363: 15-16, 1993
65. Andersen, A. S., Kjeldsen, T., Wiberg, F. C., Christensen, P. M., Rasmussen, J. S , Norris, K , Moller, K. B., and Moller, N. P. H. Changing the insulin receptor to possess insulin-like growth factor I ligand specificity. Biochemistry, 29: 7363-7366, 1990
66. Schumacher, R., Soos, M. A , Schlessinger, J., Brandenburg, D., Siddle, K , and Ulirich, A. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants. J. Biol. Chem., 268: 1087-1094, 1993.
67. O'Bryan, J P., Fridell, Y. W., Koski, R., Vamum, B , and Liu, E. T The transforming receptor tyrosine kinase. Axl. is post-translationally regulated by proteolytic cleavage. J. Biol. Chem., 270: 551-557, 1995.
68. Papa, V , Russo, P., Gliozzo, B., Goldfine, I. D., Vignen, R., and Pezzino, V An intact and functional soluble form of the insulin receptor is secreted by cultured cells. Endocrinology, 133: 1369-1376, 1993.